With increasing biomarker-driven cancer treatments, TEPMETKO benefits from growing adoption in precision oncology. Competition from other MET inhibitors like TABRECTA (capmatinib) exists, but ...

Merck (MRK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

AbbVie ABBV announced that it has entered into a licensing agreement with Denmark-based biotech Gubra for the latter’s ...

In the business of drug development, deals can be just as important as scientific breakthroughs. Many of today's most lucrative medicines, from the life-saving cancer treatment Keytruda to the ...

We believe investors with a long-term horizon should stay invested in MRK stock, while short-term investors should consider selling the same.

Eisai plans to lay off 121 employees in the U.S. A former deputy director of China's drug agency is under investigation by anti-corruption authorities. | Eisai plans to lay off 121 employees in the U.

While Merck reported strong financial results in recent quarters, it faces both upsides and risks in the future. Read why I'm ...

China’s DeepSeek shocked the world by delivering unexpected innovation at an unbelievable price. But this disruptive trend isn’t confined to Big Tech: It has been quietly happening in the ...

--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Merck & Co (“Merck” or the “Company ...

Global specialty chemicals and industrial gases giants Merck and Linde are considering setting up manufacturing facilities in India to cater to the country’s growing semiconductor industry ...